BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20639728)

  • 1. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
    Toma J; Whitcomb JM; Petropoulos CJ; Huang W
    AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.
    Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG
    J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
    Pontow S; Ratner L
    J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.
    Cilliers T; Nhlapo J; Coetzer M; Orlovic D; Ketas T; Olson WC; Moore JP; Trkola A; Morris L
    J Virol; 2003 Apr; 77(7):4449-56. PubMed ID: 12634405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
    Whitcomb JM; Huang W; Fransen S; Limoli K; Toma J; Wrin T; Chappey C; Kiss LD; Paxinos EE; Petropoulos CJ
    Antimicrob Agents Chemother; 2007 Feb; 51(2):566-75. PubMed ID: 17116663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
    Soulié C; Tubiana R; Simon A; Lambert-Niclot S; Malet I; Canestri A; Brunet C; Murphy R; Katlama C; Calvez V; Marcelin AG
    J Acquir Immune Defic Syndr; 2009 May; 51(1):60-4. PubMed ID: 19390328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
    Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
    Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.
    Gorry PR; Bristol G; Zack JA; Ritola K; Swanstrom R; Birch CJ; Bell JE; Bannert N; Crawford K; Wang H; Schols D; De Clercq E; Kunstman K; Wolinsky SM; Gabuzda D
    J Virol; 2001 Nov; 75(21):10073-89. PubMed ID: 11581376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordant utilization of macrophage entry coreceptors by related variants within an HIV type 1 primary isolate viral swarm.
    Singh A; Yi Y; Isaacs SN; Kolson DL; Collman RG
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):957-63. PubMed ID: 11461681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
    J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
    Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ
    AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
    Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
    Yao Q; Compans RW; Chen C
    Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.